ClinConnect ClinConnect Logo
Search / Trial NCT06057142

Reciting Tang Poems to Promote Happiness

Launched by HONG KONG METROPOLITAN UNIVERSITY · Sep 21, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tang Poems Happiness Ethnic Minority Students

ClinConnect Summary

This clinical trial, titled "Reciting Tang Poems to Promote Happiness," is exploring how reading and reciting traditional Chinese Tang poems can help increase happiness and well-being among primary school children from ethnic minority backgrounds in Hong Kong. The study involves fun sessions where children will recite Tang poems together, and the researchers want to see if those who recite more poems feel happier and more engaged. The trial is currently looking for participants, specifically children aged 6 to 12 who are in Grades 1 or 2 and can communicate in simple Cantonese or English.

To participate, children need to have permission from their parents, and they must be able to engage with the activities. Those who are physically or mentally unable to communicate, don’t want to join even if their parents agree, or are already very familiar with Tang poems won’t be eligible. During the trial, participants can expect to take part in three poetry recitation sessions and one performance, making it a fun and interactive way to explore poetry while potentially boosting their happiness!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ethnic minority children in primary schools (Grades 1-2, age 6-12)
  • Able to communicate using either simple Cantonese or English
  • With parental consent, and consent of the child as confirmed by the parent and our research team at the session
  • Exclusion Criteria:
  • Physically or mentally unable to communicate
  • Unwilling to participate regardless of parental consent
  • Being involved in other similar activities or research
  • Already proficient in Tang poems, being able to recite more than one poem

About Hong Kong Metropolitan University

Hong Kong Metropolitan University (HKMU) is a leading institution committed to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, HKMU leverages its robust academic resources and expertise to facilitate innovative research initiatives aimed at improving patient care and health outcomes. The university fosters collaboration among multidisciplinary teams, ensuring adherence to rigorous ethical standards and regulatory compliance throughout the research process. HKMU's commitment to excellence in clinical research not only enhances its academic reputation but also contributes significantly to the advancement of medical science and public health.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Yuying Sun, PhD

Principal Investigator

Hong Kong Metropolitan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported